Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Estrella

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
JAMA Health Forum|August 17, 2022
Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan TypesSri Lekha Tummalapalli, Julio Lamprea Montealegre, Neil Warnock, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 16, 2025
Sodium-Glucose Cotransporter-2 Inhibitor Therapy and Longitudinal Changes in Kidney Function among Veterans with Autosomal Dominant Polycystic Kidney DiseaseMeghana Eswarappa, Erin Madden, Michael G Shlipak, et al.
Clinical Kidney Journal|August 8, 2015
Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case seriesSana Waheed, Doaa Attia, Michelle M Estrella, et al.
Kidney Medicine|August 17, 2021
Urinary Biomarkers and Kidney Outcomes: Impact of Indexing Versus Adjusting for Urinary CreatinineNicholas Wettersten, Ronit Katz, Michael G Shlipak, et al.
Mayo Clinic Proceedings|October 9, 2022
Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With ProteinuriaChi D Chu, Neil R Powe, Michelle M Estrella, et al.
AIDS Research and Human Retroviruses|June 14, 2013
Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected menAlison G Abraham, Xiuhong Li, Lisa P Jacobson, et al.
Plos One|April 17, 2019
Correction: HIV Viremia and T-cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin CBhavna Bhasin, Bryan Lau, Mohamed G Atta, et al.
Plos One|December 31, 2013
HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin CBhavna Bhasin, Bryan Lau, Mohamed G Atta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2015
Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK)Teresa K Chen, Michelle M Estrella, Brad C Astor, et al.
Medicine|August 23, 2011
The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): a biopsy studyElizabeth George, Girish N Nadkarni, Michelle M Estrella, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
JAMA Health Forum|August 17, 2022
Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan TypesSri Lekha Tummalapalli, Julio Lamprea Montealegre, Neil Warnock, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 16, 2025
Sodium-Glucose Cotransporter-2 Inhibitor Therapy and Longitudinal Changes in Kidney Function among Veterans with Autosomal Dominant Polycystic Kidney DiseaseMeghana Eswarappa, Erin Madden, Michael G Shlipak, et al.
Clinical Kidney Journal|August 8, 2015
Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case seriesSana Waheed, Doaa Attia, Michelle M Estrella, et al.
Kidney Medicine|August 17, 2021
Urinary Biomarkers and Kidney Outcomes: Impact of Indexing Versus Adjusting for Urinary CreatinineNicholas Wettersten, Ronit Katz, Michael G Shlipak, et al.
Mayo Clinic Proceedings|October 9, 2022
Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With ProteinuriaChi D Chu, Neil R Powe, Michelle M Estrella, et al.
AIDS Research and Human Retroviruses|June 14, 2013
Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected menAlison G Abraham, Xiuhong Li, Lisa P Jacobson, et al.
Plos One|April 17, 2019
Correction: HIV Viremia and T-cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin CBhavna Bhasin, Bryan Lau, Mohamed G Atta, et al.
Plos One|December 31, 2013
HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin CBhavna Bhasin, Bryan Lau, Mohamed G Atta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2015
Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK)Teresa K Chen, Michelle M Estrella, Brad C Astor, et al.
Medicine|August 23, 2011
The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): a biopsy studyElizabeth George, Girish N Nadkarni, Michelle M Estrella, et al.
Pageof 21